Recombinant ILDR2 (Bapotulimab Biosimilar) antibody (PE)

Catalog No. ABIN7867327

The PE-conjugated Human Monoclonal anti-ILDR2 (Bapotulimab Biosimilar) antibody (ABIN7867327) specifically detects ILDR2 (Bapotulimab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant ILDR2 (Bapotulimab Biosimilar) antibody (PE) (ABIN7867327)

Target: ILDR2 (Bapotulimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This ILDR2 (Bapotulimab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-ILDR2 (Bapotulimab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-ILDR2(bapotulimab biosimilar) mAb

Isotype: IgG2, S257A

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for ILDR2 (Bapotulimab Biosimilar)

Target: ILDR2 (Bapotulimab Biosimilar)

Alternative Name: bapotulimab biosimilar

Target Type: Biosimilar

Background:

Synonyms: C1orf32, Angulin-3,BAY-1905254

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: Q71H61